Analyst Activity – HC Wainwright Reiterates Buy on Acorda Therapeutics (NASDAQ:ACOR)

ME Staff
-
0

Analyst Ratings For Acorda Therapeutics (NASDAQ:ACOR)

Today, HC Wainwright reiterated its Buy rating on Acorda Therapeutics (NASDAQ:ACOR) with a price target of $31.00.

Some recent analyst ratings include

  • 1/17/2018-HC Wainwright Reiterated Rating of Buy .
  • 1/9/2018-JPMorgan Chase & Co. Reiterated Rating of Hold.
  • 11/28/2017-Piper Jaffray Companies Reiterated Rating of Neutral.
  • 11/17/2017-Cowen Reiterated Rating of Buy.
  • 11/16/2017-Raymond James Financial was Downgraded by analysts at Raymond James Financial from a “Market Perform ” rating to a ” Underperform” rating. They now have a $13.00 price target on the stock, up previously from $7.00 .
  • 11/16/2017-Stifel Nicolaus was Downgraded by analysts at Stifel Nicolaus from a “Buy ” rating to a ” Hold” rating. They now have a $15.00 price target on the stock, up previously from $26.00 .


  • On 12/1/2017 Burkhard Blank, Insider, sold 11,050 with an average share price of $20.53 per share and the total transaction amounting to $226,856.50.
  • On 10/9/2017 David Lawrence, Insider, sold 250 with an average share price of $25.40 per share and the total transaction amounting to $6,350.00.
  • On 8/29/2017 Scopia Capital Management Lp, Major Shareholder, bought 766,201 with an average share price of $19.23 per share and the total transaction amounting to $14,734,045.23.
  • On 8/1/2017 Barry E Greene, Director, sold 10,000 with an average share price of $21.57 per share and the total transaction amounting to $215,700.00.
  • On 7/31/2017 Lorin Randall, Director, sold 10,000 with an average share price of $21.66 per share and the total transaction amounting to $216,600.00.
  • On 6/16/2017 Ron Cohen, Insider, bought 20,000 with an average share price of $16.95 per share and the total transaction amounting to $339,000.00.
  • On 5/15/2017 Andrew A Hindman, Insider, sold 7,704 with an average share price of $15.75 per share and the total transaction amounting to $121,338.00.

Recent Trading Activity for Acorda Therapeutics (NASDAQ:ACOR)
Shares of Acorda Therapeutics closed the previous trading session at 24.95 down -0.10 0.40% with 26699 shares trading hands.